Parasitic Infections and Biological Therapies Targeting Type 2 Inflammation: a Vigibase® Study.
- DOI
- 10.1183/13993003.congress-2023.oa1421
- Published
- 2023-09-09
- Container
- Airway pharmacology and treatment
- Publisher
- European Respiratory Society
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1183/13993003.congress-2023.oa1421,
title = {Parasitic Infections and Biological Therapies Targeting Type 2 Inflammation: a Vigibase® Study.},
author = {Laurent Guilleminault and François Montastruc and Laurent L. Reber and Jean-François Magnaval and Philippine Lifar},
year = {2023},
journal = {Airway pharmacology and treatment},
doi = {10.1183/13993003.congress-2023.oa1421},
url = {https://doi.org/10.1183/13993003.congress-2023.oa1421}
}RIS
TY - JOUR TI - Parasitic Infections and Biological Therapies Targeting Type 2 Inflammation: a Vigibase® Study. AU - Laurent Guilleminault AU - François Montastruc AU - Laurent L. Reber AU - Jean-François Magnaval AU - Philippine Lifar PY - 2023 JO - Airway pharmacology and treatment DO - 10.1183/13993003.congress-2023.oa1421 UR - https://doi.org/10.1183/13993003.congress-2023.oa1421 ER -
APA
Guilleminault, L., Montastruc, F., Reber, L. L., Magnaval, J., & Lifar, P. (2023). Parasitic Infections and Biological Therapies Targeting Type 2 Inflammation: a Vigibase® Study.. Airway pharmacology and treatment. https://doi.org/10.1183/13993003.congress-2023.oa1421
Source records
- crossref · retrieved 2026-09-27T06:01:41.661Z